Ecron Acunova expands Asian presence with Thai academic alliance
This article was originally published in Scrip
The India-based contract research organisation Ecron Acunova has set up a 74%-owned joint venture with a leading academic centre in Thailand, through which it will offer clinical and other development services in key Southeast Asian markets.
You may also be interested in...
Positive clinical results pave path forward for Japanese firm’s potential istradefylline successor.
Curon thinks tenalisib can offer a differentiated and safe new therapy for hematologic cancers such as multiple forms of lymphoma. Axis and PharmaEssentia team up on TCR therapy R&D in Taiwan.
Recent moves show Chinese biotech firms are increasingly looking to go global by recruiting world-class development talent, and J&J names new APAC pharma head.